Pre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study

Publication date

2022-11-09

Authors

Pham, Thu-Thi
Nimptsch, Katharina
Aleksandrova, Krasimira
Jenab, Mazda
Reichmann, Robin
Wu, Kana
Tjønneland, Anne
Kyrø, Cecilie
Schulze, Matthias B
Kaaks, Rudolf

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

Resistin is a polypeptide implicated in inflammatory processes, and as such could be linked to colorectal carcinogenesis. In case-control studies, higher resistin levels have been found in colorectal cancer (CRC) patients compared to healthy individuals. However, evidence for the association between pre-diagnostic resistin and CRC risk is scarce. We investigated pre-diagnostic resistin concentrations and CRC risk within the European Prospective Investigation into Cancer and Nutrition using a nested case-control study among 1293 incident CRC-diagnosed cases and 1293 incidence density-matched controls. Conditional logistic regression models controlled for matching factors (age, sex, study center, fasting status, and women-related factors in women) and potential confounders (education, dietary and lifestyle factors, body mass index (BMI), BMI-adjusted waist circumference residuals) were used to estimate relative risks (RRs) and 95% confidence intervals (CIs) for CRC. Higher circulating resistin concentrations were not associated with CRC (RR per doubling resistin, 1.11; 95% CI 0.94-1.30; p = 0.22). There were also no associations with CRC subgroups defined by tumor subsite or sex. However, resistin was marginally associated with a higher CRC risk among participants followed-up maximally two years, but not among those followed-up after more than two years. We observed no substantial correlation between baseline circulating resistin concentrations and adiposity measures (BMI, waist circumference), adipokines (adiponectin, leptin), or metabolic and inflammatory biomarkers (C-reactive protein, C-peptide, high-density lipoprotein cholesterol, reactive oxygen metabolites) among controls. In this large-scale prospective cohort, there was little evidence of an association between baseline circulating resistin concentrations and CRC risk in European men and women.

Keywords

colorectal cancer, inflammation, pre-diagnostic resistin, prospective, risk, Oncology, Cancer Research, Journal Article

Citation

Pham, T-T, Nimptsch, K, Aleksandrova, K, Jenab, M, Reichmann, R, Wu, K, Tjønneland, A, Kyrø, C, Schulze, M B, Kaaks, R, Katzke, V, Palli, D, Pasanisi, F, Ricceri, F, Tumino, R, Krogh, V, Roodhart, J, Castilla, J, Sánchez, M-J, Colorado-Yohar, S M, Harbs, J, Rutegård, M, Papier, K, Aglago, E K, Dimou, N, Mayen-Chacon, A-L, Weiderpass, E & Pischon, T 2022, 'Pre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study', Cancers, vol. 14, no. 22, 5499. https://doi.org/10.3390/cancers14225499